BioSpace News Archive

Celsion Corporation (NASDAQ: CLSN), Celsion GmbH, a wholly owned subsidiary of Celsion Corporation, a clinical-stage biotechnology company, announces commencement of enrollment in Oxford University’s Phase I PanDox study with ThermoDox® in conjunction with Focused Ultrasound in patients with pancreatic cancer.

Aileron Therapeutics, Inc. (Nasdaq: ALRN) today announced that it has initiated a randomized, double-blind, placebo-controlled clinical trial in the US and in Europe of ALRN-6924 as a chemoprotective agent to treat patients with non-small cell lung cancer (NSCLC) undergoing chemotherapy

Kintara Therapeutics, Inc. today announced topline data results from the recurrent arm of its open-label, Phase 2 clinical study of its lead compound VAL-083.

Adverum Biotechnologies, Inc. today announced the appointment of Jon Williams, Ph.D., as vice president, clinical affairs, effective immediately.

NS Pharma, Inc. (NS Pharma; President, Tsugio Tanaka), a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku; President, Toru Nakai), announced that new long-term efficacy and safety data based on interim analyses at 109 weeks from the open-label extension trial of a Phase 2 study of VILTEPSO® (viltolarsen) injection were presented at the PPMD 2021 Annual Conference.

Lupin Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental New Drug Application (sNDA) to expand the use of SOLOSEC®

Karyopharm Therapeutics Inc. announced that in connection with the hiring of Ms. Sohanya Cheng, Senior Vice President, Sales and Commercial Operations, the Compensation Committee of Karyopharm’s Board of Directors granted a stock option to purchase 125,000 shares of Karyopharm’s common stock to Ms. Cheng, with a grant date of June 30, 2021.

Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, launched a new application suite for the characterization of nanoparticles on Stunner today.

The American College of Medical Genetics and Genomics (ACMG) has released its first Evidence-based Clinical Practice Guideline (EBG), " Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics.

Pulse Biosciences, Inc. today announced that it has entered into a stock purchase agreement with Robert W. Duggan for the purchase of 3,048,780 shares of the Company’s common stock at a price of $16.40 per share.